Old Web
English
Sign In
Acemap
>
Paper
>
Use of 7.5 mg/kg of bevacizumab to palliate symptomatic malignant ascites in recurrent ovarian cancer
Use of 7.5 mg/kg of bevacizumab to palliate symptomatic malignant ascites in recurrent ovarian cancer
2018
Y. Shimizu
T. Nakanishi
K. Sasamoto
S. Kondo
Keywords:
Recurrent Ovarian Cancer
Bevacizumab
Ascites
Internal medicine
Medicine
Pathology
Gastroenterology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]